Patent applications published 9 November 2011
Selected patent applications from the weekly European Patents Bulletin
- A compsn comprising noradrenaline and a net inhibitor for administering to a brain-dead, heart-beating potential organ donor
Vivoline Medical 2381412*
- Nutraceuticals containing nitro fatty acids
Nitromega 2384114*
- Methods and compsns for treating haematological malignancies
Genzyme Corp 2384115*
- Dominant negative WNT2 compsns and methods of use
The Regents of the University of California 2384116*
- Sphingo-guanidines and their use as inhibitors of sphingosine kinase
MUSC Foundation for Research Development 2384118*
- Pharmaceutical compsn comprising racemic aminopterin
Syntrix Biosystems 2384119*
- Adjuvant compsns and methods of use
Epitogenesis 2384120*
- Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment thereof
Thrombologic 2384196*
- Use of LNA APOB antisense oligomers for the treatment of acute coronary syndromes
Santaris Pharma 2384197*
- Pharmaceutical compsns and methods of treating neurological insults
Endogenx 2384198*
- Enhanced medical implant
Wasielewsi, Ray 2384199*
- Alanine-glyoxylate aminotransferase therapeutics
Amsterdam Molecular Therapeutics 2384200*
- Polypeptides for inducing a protective immune response against Staphylococcus aureus
Merck Sharp & Dohme 2384201*
- A dominant negative mutants of SAM68 for use in the treatment of spinal muscular atrophy (SMA)
Fondazione Santa Lucia 2384202*
- Contrast agents for medical microwave imaging
The University of Bristol 2384203*
- Fibrin and fibrinogen matrices and uses of same
Ramot at Tel-Aviv University 2384205*
- Medical implants and methods of making medical implants
Batelle Memorial Institute 2384206*
- Pyrrolidine compounds which modulate the CB2 receptor
Boehringer Ingelheim International 2384320*
- Intravascular contrast agents
Nanynag Technological University; Agency for Science, Technology & Research 2384323*
- Process for the preparation of efavirenz
FIS Fabbrica Intalina Sintecici 2384324*
- Pyrrolo92,3-D)pyrimidine compounds
Pfizer 2384326*
- Fused ring compound and use thereof
Takeda Pharmaceutical 2384327*
- 6,7,8,9-tetrahydro-5H-1,4,7,20A-tetraaza-cyclohept[F]indene derivatives, pharmaceutical compsns containing these compounds, their use and process for preparing them
Boehringer Ingelheim International 2384328*
- Novel fluorescent boron-substituted dipyrromethenes and use thereof for diagnosis
Centre National de la Recherche Scientifique; Universite de Strasbourg 2384329*
- Process for preparing bis- and tris(silylorgano)amines
Wacker Chemie 2384330*
- Mixed glycol polyphosphonate compounds
Albemarle 2384331*
- 9-deoxo-9A-methyl-9A-aza-9A-homoerythormycin A derivatives for the treatment of neutrophil dominated inflammatory diseases
Glaxo Group 2384332*
- Anti-inflammatory macrolide
Glaxo Group 2384333*
- A method of producing a novel opioid peptide
Action for Development of Research 2384334*
- Biosurfactant compsn produced by a new Bacillus licheniformis strain, uses and products thereof
Pan-Eco; University Technologies International 2384335*
- A variant of mite allergen and uses thereof
Chua, Kaw Yan 2384336*
- Means and method for the treatment of antibody deficiency diseases based on Il-21 and IL-21 variants
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung 2384337*
- GLP-1 analogues and uses thereof
Panacea Biotec 2384338*
- Treatment of autoimmune disease by modulating annexin-1 (lipocortin-1)
Queen Mary & Westfield College 2384339*
- Organic solvent pretreatment of biomass to enhance enzymatic saccharification
EI du Pont de Nemours 2384364*
- Serum markers predicting clinical response to anti-TNF antibodies in patients with ankylosing spondylitis
Janssen Biotech 2384367*
- Gene dosage analysis
Kantonsspital Aarau 2384368*
- Adult stem cell assays
KCI Licensing 2384369*
- Use of ID4 for diagnosis and treatment of cancer
John Wayne Cancer Institute 2384370*
- Hydrogels cross-linked with gold nanoparticles
University of Utah Research Foundation 2384439*
- Synthetic peptides, methods and kits for diagnosing autoimmune diseases
Flysun Development 2384440*
- Isolated peptides of rabbit factor VII
LFB Biotechnologies 2384441*
- Dosage regimen of an S1P agonist
Novartis 2384749*
- Improved glycaemic control for prediabetes and/or diabetes type II using docohexaenoic acid
Martek Biosciences 2384750*
- Medicaments for the treatment or prevention of fibrotic diseases
Boehringer Ingelheim International 2384751*
- Combination preparation comprising a phosphodiesterase inhibitor and a COX inhibitor for treating cancer
Universitätsklinikum Hamburg-Eppendorf 2384752*
- Hydantoin derivatives as inhibitors of cellular necrosis
The Brigham and Women’s Hospital; President and Fellows of Harvard College 2384753*
- Pharmaceutical dosage forms
Purdue Pharma 2384754*
- Eslicarbazepine acetate and methods of use
Bial-Portela 2384755*
- High-purity large-scale preparation of stannsoporfin
InfaCare Pharmaceutical 2384756*
- Prevention and/or treatment of neurodegenerative disorders
The University of Liverpool 2384757*
- Polyacetylenic compounds
Academia Sinica 2384758*
- Sulphated hyaluronic acid in combination with G-CSF for use in mobilising blood stem cells
Suomen Punainen Rosti Veripalvelu; Glykos Finland 2384759*
- Sulphated hyaluronic acid in combination with G-CSF for use in mobilising blood stem cells
Suomen Punainen Rosti Veripalvelu; Glykos Finland 2384760*
- Modified rodent parvovirus capable of propagating and spreading through human gliomas
Deutsches Krebsforschungszentrum 2384761*
- Use of extracts obtained from plants of the family Canallaceae in treatment of cancer
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung 2384762*
- A peptide ligand to impair cancer cell migration
Wntresearch 2384763*
- Compsns and methods for modulating haemistasis using variant forms of activated factor V
The Children’s Hospital of Philadelphia 2384764*
- Streptococcus pneumoniae vaccine
GlaxoSmithKline Biologicals 2384765*
- Novel antibody to a carbonic anhydrase
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt 2384766*
- Antibodies that bind OV064 and methods of use therefor
Millennium Pharmaceuticals 2384767*
- Phenylpropionamide compounds and the use thereof
Purdue Pharma 2384768*
- Ophthalmic visualisation compounds and methods of using same
Allergan 2384769